QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序作者升序作者降序提交时间升序提交时间降序题名升序题名降序 Effects of a High-fat Meal on the Pharmacokinetics of the VEGFR Inhibitor Fruquintinib: A Randomized Phase I Study in Healthy Subjects 期刊论文 CLINICAL THERAPEUTICS, 2019, 卷号: 41, 期号: 8 作者:  Liu, Yun;  Li, Tingting;  Wang, Wei;  Jia, Jingying;  Liu, Yanmei 收藏  |  浏览/下载：28/0  |  提交时间：2019/12/05 food effect  fruquintinib  healthy Chinese subjects  pharmacokinetics  Phase I  tolerability   The clinical application of fruquintinib on colorectal cancer 期刊论文 EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 卷号: 12, 期号: 8, 页码: 713-721 作者:  Chen, Zhongguang;  Jiang, Lili 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/11 Fruquintinib  EGFR  VEGF  VEGFR  CRC   Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer: The FRESCO Randomized Clinical Trial. 期刊论文 JAMA, 2018, 卷号: 319, 期号: 24, 页码: 2486-2496 作者:  Li, Jin;  Qin, Shukui*;  Xu, Rui-Hua;  Shen, Lin;  Xu, Jianming 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/03 adverse event  chemotherapy regimen  china  colorectal cancer metastatic  fruquintinib  toxic effect  tumor progression  vascular endothelial growth factor receptors   Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study 期刊论文 JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 卷号: 10 作者:  Xu, Rui-Hua;  Li, Jin;  Bai, Yuxian;  Xu, Jianming;  Liu, Tianshu 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Fruquintinib  Metastatic colorectal cancer  Progression-free survival  VEGFR   A Phase I study of safety and pharmacokinetics of fruquintinib, a novel selective inhibitor of vascular endothelial growth factor receptor-1,-2, and-3 tyrosine kinases in Chinese patients with advanced solid tumors 期刊论文 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 卷号: 78, 期号: 2 作者:  Cao, Junning;  Zhang, Jian;  Peng, Wei;  Chen, Zhiyu;  Fan, Songhua 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/06 Fruquintinib  Phase I study  VEGFR  Advanced solid tumors  Safety and pharmacokinetics